Get the Stockscreener App
3.26
1.87%
0.06
After Hours:
3.26
Sight Sciences Inc stock is traded at $3.26, with a volume of 51,285.
It is up +1.87% in the last 24 hours and down -5.78% over the past month.
Sight Sciences Inc is an ophthalmic medical device company focused on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. Its Surgical Glaucoma segment's product portfolio features the OMNI Surgical System, a device that facilitates the performance of both canaloplasty and trabeculotomy with a single device and single corneal incision to reduce intraocular pressure in adult patients with primary open-angle glaucoma. The company's Dry Eye segment's product portfolio consists of the TearCare System for ophthalmologists and optometrists. It derives key revenue from the Surgical Glaucoma segment.
See More
Previous Close:
$3.20
Open:
$3.25
24h Volume:
51,285
Relative Volume:
0.46
Market Cap:
$170.72M
Revenue:
$81.06M
Net Income/Loss:
$-55.55M
P/E Ratio:
-2.8596
EPS:
-1.14
Net Cash Flow:
$-47.98M
1W Performance:
-2.98%
1M Performance:
-5.78%
6M Performance:
+36.97%
1Y Performance:
-43.21%
1-Day Range:
$3.215
$3.38
1-Week Range:
$3.19
$3.52
52-Week Range:
$2.03
$6.29
Sight Sciences Inc Stock (SGHT) Company Profile
Name
Sight Sciences Inc
Sector
Industry
Phone
(415) 889-0550
Address
4040 CAMPBELL AVE,, MENLO PARK
Compare SGHT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SGHT
Sight Sciences Inc
|
3.26 | 167.58M | 81.06M | -55.55M | -47.98M | -1.14 |
|
ABT
Abbott Laboratories
|
131.38 | 230.73B | 43.11B | 13.94B | 6.78B | 7.9963 |
|
BSX
Boston Scientific Corp
|
94.95 | 141.37B | 18.49B | 2.50B | 3.49B | 1.6801 |
|
SYK
Stryker Corp
|
364.92 | 139.39B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
MDT
Medtronic Plc
|
95.58 | 122.43B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
72.95 | 43.41B | 5.69B | 1.41B | 577.90M | 6.9828 |
Sight Sciences Inc Stock (SGHT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Aug-08-25 | Upgrade | Lake Street | Hold → Buy |
| Dec-06-24 | Initiated | UBS | Buy |
| Nov-04-24 | Downgrade | Lake Street | Buy → Hold |
| Aug-21-24 | Initiated | Lake Street | Buy |
| Sep-12-23 | Downgrade | BofA Securities | Neutral → Underperform |
| Sep-12-23 | Downgrade | Piper Sandler | Overweight → Neutral |
| Sep-12-23 | Downgrade | William Blair | Outperform → Mkt Perform |
| Aug-24-23 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jul-10-23 | Downgrade | Citigroup | Buy → Neutral |
| Jan-06-23 | Upgrade | Stifel | Hold → Buy |
| Oct-04-22 | Initiated | Needham | Hold |
| Jul-26-22 | Initiated | Stifel | Hold |
| Feb-03-22 | Initiated | William Blair | Outperform |
| Jan-07-22 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
View All
Sight Sciences Inc Stock (SGHT) Latest News
Is it time to cut losses on Sight Sciences Inc.Portfolio Return Report & Fast Gain Stock Trading Tips - newser.com
Is Sight Sciences Inc. stock a defensive play in 20252025 Investor Takeaways & Safe Entry Momentum Tips - newser.com
Can machine learning forecast Sight Sciences Inc. recoveryEntry Point & Low Drawdown Trading Strategies - newser.com
Is a relief rally coming for Sight Sciences Inc. holdersQuarterly Market Review & Community Consensus Trade Signals - newser.com
Why Sight Sciences Inc. stock is trending among retail tradersAnalyst Downgrade & Verified Momentum Stock Ideas - newser.com
How Sight Sciences Inc. stock responds to policy changesGap Down & Smart Money Movement Alerts - newser.com
What analysts say about Sight Sciences Inc stockStraddle and Strangle Trades & Low Entry Risk Stocks - earlytimes.in
What does recent volatility data suggest for Sight Sciences Inc.July 2025 Breakouts & Safe Capital Growth Tips - newser.com
Sector ETF performance correlation with Sight Sciences Inc.Take Profit & Risk Adjusted Buy/Sell Alerts - newser.com
Does Sight Sciences Inc. qualify in momentum factor screeningQuarterly Performance Summary & Community Verified Watchlist Alerts - newser.com
Live market analysis of Sight Sciences Inc.2025 Support & Resistance & Growth Focused Investment Plans - newser.com
Intraday pattern recognizer results for Sight Sciences Inc.July 2025 Patterns & Fast Exit and Entry Strategy Plans - newser.com
Evp Taylor Brenton sells Sight Sciences (SGHT) shares for $1,991 By Investing.com - Investing.com Canada
Sight Sciences (NASDAQ:SGHT) Earns Sell (D-) Rating from Weiss Ratings - MarketBeat
Sight Sciences (NASDAQ:SGHT) Given New $4.00 Price Target at Citigroup - Defense World
Citigroup Lowers Sight Sciences (NASDAQ:SGHT) Price Target to $4.00 - MarketBeat
Using AI based signals to follow Sight Sciences Inc.Quarterly Portfolio Report & Target Return Focused Picks - newser.com
How Sight Sciences Inc. stock performs in interest rate cyclesWeekly Market Summary & Low Drawdown Investment Ideas - newser.com
Chart based analysis of Sight Sciences Inc. trendsQuarterly Portfolio Review & Low Risk High Win Rate Picks - newser.com
Can you recover from losses in Sight Sciences Inc.2025 Price Momentum & Scalable Portfolio Growth Ideas - newser.com
Using data filters to optimize entry into Sight Sciences Inc.Share Buyback & Consistent Return Strategy Ideas - newser.com
What’s next for Sight Sciences Inc. stock price2025 Risk Factors & Daily Stock Trend Watchlist - newser.com
David Badawi Sells 6,033 Shares of Sight Sciences (NASDAQ:SGHT) Stock - MarketBeat
Jeremy Hayden Sells 9,731 Shares of Sight Sciences (NASDAQ:SGHT) Stock - MarketBeat
Technical analysis overview for Sight Sciences Inc. stockWeekly Stock Analysis & AI Optimized Trading Strategy Guides - newser.com
What indicators show strength in Sight Sciences Inc.July 2025 Reactions & Daily Profit Focused Stock Screening - newser.com
Sight Sciences, Inc. (NASDAQ:SGHT) Given Consensus Rating of "Hold" by Analysts - MarketBeat
Sight Sciences Inc Stock Analysis and ForecastLong-Term Investment Plans & Maximize Gains Professionally - earlytimes.in
Sight Sciences says available draw increased to $25 million under amendmentSEC filing - MarketScreener
Sight Sciences Amends Loan Agreement with Hercules - TipRanks
Sight Sciences, Inc. Amends Loan Agreement With Hercules Capital To Extend Interest-Only Period And Reallocate Tranche - MarketScreener
Sight Sciences Inc Stock (SGHT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.01%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):